Gotowa bibliografia na temat „Killer immunoglobulin like receptors (KIR)”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Killer immunoglobulin like receptors (KIR)”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Killer immunoglobulin like receptors (KIR)"
Hidajat, Melanny, Dominik Selleslag, Achiel Van Hoof, Jan Van Droogenbroeck, Johan Billiet i Arnold Criel. "Killer Immunoglobulin-Like Receptors (KIRs) Genotypes in a Belgian Population." Blood 104, nr 11 (16.11.2004): 3852. http://dx.doi.org/10.1182/blood.v104.11.3852.3852.
Pełny tekst źródłaCremer, Anja, Ute Heider, Stefan Tomiuk, Andreas Arendt, Jurgen Schmitz, Andreas Bosio, Volker Huppert i Christian Biervert. "Integrated Genotyping and mRNA Expression Profiling of Killer Immunoglobulin-Like Receptors." Blood 106, nr 11 (16.11.2005): 3909. http://dx.doi.org/10.1182/blood.v106.11.3909.3909.
Pełny tekst źródłaLuc-Aimé, Kagoué Simeni, Yindom Louis-Marie, Loni Ekali Gabriel, Clauvis Kunkeng Yengo, F. Esemu Livo i Nguedia Jules Clement Assob. "Killer-Cell Immunoglobulin-Like Receptors (KIR) in HIV-Exposed Infants in Cameroon". Journal of Immunology Research 2021 (13.01.2021): 1–7. http://dx.doi.org/10.1155/2021/9053280.
Pełny tekst źródłaParham, Peter, Paul J. Norman, Laurent Abi-Rached i Lisbeth A. Guethlein. "Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules". Philosophical Transactions of the Royal Society B: Biological Sciences 367, nr 1590 (19.03.2012): 800–811. http://dx.doi.org/10.1098/rstb.2011.0266.
Pełny tekst źródłaTreanor, Bebhinn, Peter M. P. Lanigan, Sunil Kumar, Chris Dunsby, Ian Munro, Egidijus Auksorius, Fiona J. Culley i in. "Microclusters of inhibitory killer immunoglobulin–like receptor signaling at natural killer cell immunological synapses". Journal of Cell Biology 174, nr 1 (26.06.2006): 153–61. http://dx.doi.org/10.1083/jcb.200601108.
Pełny tekst źródłaAbi-Rached, Laurent, i Peter Parham. "Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues". Journal of Experimental Medicine 201, nr 8 (18.04.2005): 1319–32. http://dx.doi.org/10.1084/jem.20042558.
Pełny tekst źródłaRettman, Pauline, Matthew D. Blunt, Rebecca J. Fulton, Andres F. Vallejo, Leidy Y. Bastidas-Legarda, Laura España-Serrano, Marta E. Polak, Aymen Al-Shamkhani, Christelle Retiere i Salim I. Khakoo. "Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors". Journal for ImmunoTherapy of Cancer 9, nr 5 (maj 2021): e001912. http://dx.doi.org/10.1136/jitc-2020-001912.
Pełny tekst źródłaRajagopalan, Sumati, i Eric O. Long. "Understanding how combinations of HLA and KIR genes influence disease". Journal of Experimental Medicine 201, nr 7 (4.04.2005): 1025–29. http://dx.doi.org/10.1084/jem.20050499.
Pełny tekst źródłaDiaz-Peña, Roberto, Patricia Mondelo-Macía, Antonio José Molina de la Torre, Rebeca Sanz-Pamplona, Víctor Moreno i Vicente Martín. "Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer". Cells 9, nr 2 (24.02.2020): 514. http://dx.doi.org/10.3390/cells9020514.
Pełny tekst źródłaHarvey, D., J. J. Pointon, C. Sleator, A. Meenagh, C. Farrar, J. Y. Sun, D. Senitzer, D. Middleton, M. A. Brown i B. P. Wordsworth. "Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis". Annals of the Rheumatic Diseases 68, nr 4 (19.11.2008): 595–98. http://dx.doi.org/10.1136/ard.2008.095927.
Pełny tekst źródłaRozprawy doktorskie na temat "Killer immunoglobulin like receptors (KIR)"
Yindom, Louis Marie. "Human Leukocyte Antigen (HLA) and Killer Immunoglobulin-like Receptors (KIR) in HIV-2 Infection". Thesis, Open University, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520671.
Pełny tekst źródłaBraun, Kali. "Association of killer immunoglobulin-like receptor (KIR) genes with tuberculosis disease in two Canadian cohorts". PLoS ONE, 2013. http://hdl.handle.net/1993/22042.
Pełny tekst źródłaSepulveda, Christian Alberto Garcia. "Killer cell Immunoglobulin-like Receptor (KIR) polymorphism : functional implications and clinical relevance". Thesis, University College London (University of London), 2005. http://discovery.ucl.ac.uk/1444690/.
Pełny tekst źródłaHalfpenny, Iris A. "An investigation into the genetics of the killer immunoglobulin-like receptor (KIR) gene family". Thesis, University of Ulster, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.494359.
Pełny tekst źródłaFoley, Bree Amanda. "The immunogenetics of natural killer cell alloreactivity". University of Western Australia. School of Pathology and Laboratory Medicine, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0242.
Pełny tekst źródłaSalim, Patrícia Hartstein. "Estudo do polimorfismo dos genes KIR na esclerose sistêmica". reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2009. http://hdl.handle.net/10183/15457.
Pełny tekst źródłaNatural killer (NK) cells have an important role in the early responses to viral infections. They kill diverse target cells with decreased or absent expression of major histocompatibility complex (MHC) class I molecules through the Killer Cell Immunoglobulin-Like Receptors (KIR). Many studies have reported association of KIR genes with autoimmune diseases. The objective of this study is to investigate possible associations of KIR polymorphisms with systemic sclerosis (SSc), including the limited (lSSc) and diffuse (dSSc) forms of the disease. The frequency of inhibitory KIR2DL2 was significantly decreased among patients with SSc compared with healthy controls (28.7% versus 65.2; P<0.001, odds ratio [OR] 0.21, 95% confidence interval [95% CI] 0.11–0.38). When activatory and inhibitory KIR genes were analyzed in combination, the concomitant presence of KIR2DS2 and absence of KIR2DL2 (KI2DS2+/KIR2DL2-) phenotype was more frequent in SSc patients than in the control group (26.08% versus 1.75%; P<0.001, OR=19.94, 95%CI [4.78–175.10]). On the other hand, the presence of both KIR2DS2 and KIR2DL2 was more frequent in the control group (26.96% versus 57.39%; P=0.000005, OR=0.27, 95%CI [0.15–0.49]). No significant difference in KIR genes polymorphisms was found between lSSc and dSSc disease subsets. The combination of KIR2DS2+/KIR2DL2– may be a risk factor for development of SSc while the higher frequency of the inhibitory KIR2DL2 gene in the control group suggest to a protective effect. These results indicate a potential role of KIR genes in the SSc pathogenesis.
Ishida, Yoshihiro. "Killer immunoglobulin-like receptor genotype did not correlate with response to anti-PD-1 antibody treatment in a Japanese cohort". Kyoto University, 2020. http://hdl.handle.net/2433/253207.
Pełny tekst źródłaSilva, Pamela Portela da. "Análise de polimorfismos dos genes KIR e HLA classe I em pacientes com câncer colorretal". reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2016. http://hdl.handle.net/10183/148088.
Pełny tekst źródłaColorectal cancer (CRC) can occur anywhere in the colon or rectum and represents the third most common cancer in the world in both sexes. Natural killer cells (NK) are part of the innate immune system recognizing class I HLA molecules on target cells through their membrane receptors, called killer cell immunoglobulin-like receptors (KIR). The aim of our study was to evaluate the association between the KIR genes and HLA ligands in patients with colorectal cancer and healthy controls. We examined the polymorphism of 16 KIR genes and their HLA ligands in 154 caucasoid CRC patients and 216 healthy controls by PCR-SSO and PCR-SSP. When both groups were compared, no significant differences were found for HLA ligands and KIR genes after Bonferroni correction. However, the Bx group genotypes (heterozygous and homozygous for the haplotype B) were more frequent in controls, when compared with patients. These findings suggest that individuals with Bx genotypes could have some protection to colorectal cancer. These findings suggest that higher levels of activating KIR signals appear as protective to colorectal cancer.
Silva, Pamela Portela da. "Estudo de polimorfismos dos genes KIR e HLA em pacientes com câncer de próstata". reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2011. http://hdl.handle.net/10183/35890.
Pełny tekst źródłaProstate cancer is the second most common cancer among men, since both incidence and mortality exponentially increases in men over fifty years of age. Natural killer cells (NK) are part of the innate immune system recognizing class I HLA molecules on target cells through their membrane receptors, called killer immunoglobulin-like receptors (KIR). The aim of our study was to evaluate the association between the KIR genes and HLA alleles in patients with prostate cancer and healthy controls. Two hundred prostate cancer patients and 185 healthy controls were typed for HLA class I and KIR genes by PCR-SSP. When both groups were compared, no significant differences were found for HLA-C group 1 and group 2, HLA-Bw4, HLA-A3 and A11. No difference was seen either in KIR frequency between patients with prostate cancer and controls. In conclusion, our data suggests no potential role for the KIR gene system in prostate cancer.
Ichise, Hiroshi. "NK cell alloreactivity against KIR-ligand-mismatched HLA-haploidentical tissue derived from HLA haplotype-homozygous iPSCs". Kyoto University, 2017. http://hdl.handle.net/2433/228232.
Pełny tekst źródłaCzęści książek na temat "Killer immunoglobulin like receptors (KIR)"
Hou, Lihua, Minghua Chen, Noriko Steiner, Kanthi Kariyawasam, Jennifer Ng i Carolyn K. Hurley. "Killer Cell Immunoglobulin-Like Receptors (KIR) Typing by DNA Sequencing". W Methods in Molecular Biology™, 431–68. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-842-9_25.
Pełny tekst źródłaLi, Hongchuan, Paul W. Wright i Stephen K. Anderson. "Identification and Analysis of Novel Transcripts and Promoters in the Human Killer Cell Immunoglobulin-like Receptor (KIR ) Genes". W Methods in Molecular Biology, 377–91. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60761-362-6_26.
Pełny tekst źródłaLong, Eric O., Deborah N. Burshtyn, Christopher C. Stebbins i Carsten Watzl. "How do killer cell Ig-like receptors inhibit natural killer cells?" W Activating and Inhibitory Immunoglobulin-like Receptors, 235–41. Tokyo: Springer Japan, 2001. http://dx.doi.org/10.1007/978-4-431-53940-7_29.
Pełny tekst źródłaRajalingam, Raja, Sarah Cooley i Jeroen van Bergen. "Killer Cell Immunoglobulin-Like Receptors in Clinical Transplantation". W Manual of Molecular and Clinical Laboratory Immunology, 1150–60. Washington, DC, USA: ASM Press, 2016. http://dx.doi.org/10.1128/9781555818722.ch119.
Pełny tekst źródłaWang, Lawrence L., i Wayne M. Yokoyama. "Regulated expression of non-polymorphic gp49 molecules on mouse natural killer cells". W Activating and Inhibitory Immunoglobulin-like Receptors, 25–31. Tokyo: Springer Japan, 2001. http://dx.doi.org/10.1007/978-4-431-53940-7_4.
Pełny tekst źródłaGhansah, Tomar, John M. Ninos i William G. Kerr. "A role for the SH2-containing inositol phosphatase in the biology of natural killer cells and stem cells". W Activating and Inhibitory Immunoglobulin-like Receptors, 129–40. Tokyo: Springer Japan, 2001. http://dx.doi.org/10.1007/978-4-431-53940-7_17.
Pełny tekst źródłaRajalingam, Raja, i Elham Ashouri. "Gene-Specific PCR Typing of Killer Cell Immunoglobulin-Like Receptors". W Methods in Molecular Biology, 239–55. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-493-7_12.
Pełny tekst źródłaRuggeri, Loredana, Shuhong Zhang i Sherif S. Farag. "Natural Killer Cell Activity and Killer Immunoglobulin-Like Receptors in Hematopoietic Stem Cell Transplantation". W Cancer Treatment and Research, 47–69. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-78580-6_3.
Pełny tekst źródłaPymm, Phillip, i Julian P. Vivian. "Production of Recombinant Killer Immunoglobulin-Like Receptors for Crystallography and Luminex-Based Assays". W Methods in Molecular Biology, 281–99. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7568-6_22.
Pełny tekst źródła"Killer Immunoglobulin-Like Receptors (KIR)". W Encyclopedia of Signaling Molecules, 1001. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100688.
Pełny tekst źródłaStreszczenia konferencji na temat "Killer immunoglobulin like receptors (KIR)"
Chan, Daniel C. F., Zhiyong Zhang, Hong Wang, Xiaomei Sui, Tiffany T. Y. Chan, Natalie Ahn, Joe Phillips, Kathryn Horwitz, Lewis Lanier i Paul Bunn. "Abstract 3656: Therapeutic effects of anti-KIR antibodies against metastatic cancer cells with aberrant expression of Natural Killer-Cell Immunoglobulin-like Receptors (KIRs)". W Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3656.
Pełny tekst źródłaWang, Enxiu, Liang-Chuan Wang, Ching-Yi Tsai, Vijay Bhoj, Steven Albelda, Edmund Moon i Michael C. Milone. "Abstract B22: A chimeric antigen receptor (CARs) based upon a killer immunoglobulin-like receptor (KIR) triggers robust cytotoxic activity in solid tumors". W Abstracts: AACR Special Conference: Tumor Immunology and Immunotherapy: A New Chapter; December 1-4, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/2326-6074.tumimm14-b22.
Pełny tekst źródłaRauf, Khairunnisa Abd, Erry Gumilar Dachlan i Ariyanto Harsono. "Decidual Killer Immunoglobulin-Like Receptor (KIR)2DL1 Expression and the Onset of Preeclampsia, Birth Weight and Placental Weight in Early and Late Onset Preeclampsia". W 2nd International Conference Postgraduate School. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0007542103210324.
Pełny tekst źródłaChan, Daniel C., Zhiyong Zhang, Di Zheng, Tiffany Chan, Mary Berg, Kathryn Horwitz, Natalie Ahn, Lewis Lanier i Paul Bunn. "Abstract 4836: Immune-tolerance due to aberrant expression of Natural Killer-Cell Immunoglobulin-like Receptors (KIRs) on cancer cells and enhanced cancer-platelet interactions". W Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4836.
Pełny tekst źródłaChan, Daniel C., Zhiyong Zhang, Hong Wang, Xiaomei Sui, Tiffany T. Chan, Natalie Ahn, Lewis L. Lanier i Paul A. Bunn. "Abstract 1357: Role of Natural Killer-cell Immunoglobulin-like receptors KIR2DL1 and KIR3DL1 in immune resistance". W Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1357.
Pełny tekst źródłaNasef, SI, AM Asker, HH Omar i HM Hassoba. "SAT0304 Stimulatory and inhibitory killer immunoglobulin-like receptors on natural killer T (NKT) cells in patients with systemic lupus erythematosus (SLE): relation to disease activity". W Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3920.
Pełny tekst źródłaHagberg, N., D. Leonard, G. Nordmark i L. Rönnblom. "PS1:16 The presence of autoantibodies to multiple killer cell immunoglobulin-like receptors is associated with nephritis in sle patients". W 11th European Lupus Meeting, Düsseldorf, Germany, 21–24 March 2018, Abstract presentations. Lupus Foundation of America, 2018. http://dx.doi.org/10.1136/lupus-2018-abstract.64.
Pełny tekst źródłaRaporty organizacyjne na temat "Killer immunoglobulin like receptors (KIR)"
Varbanova, Viktoria, Snejina Mihailova, Elissaveta Naumova i Anastasiya Mihaylova. Distribution of Killer-cell Immunoglobulin-like Receptors (KIR) and their HLA Class I Ligands in the Bulgarian Population. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, lipiec 2020. http://dx.doi.org/10.7546/crabs.2020.07.14.
Pełny tekst źródła